Preemies need 1,000 IU of vitamin D – RCT
Two items on this page
Multi-dose vitamin d supplementation in stable very preterm infants: Prospective randomized trial response to three different vitamin D supplementation doses
Early Human Development. Volume 112, September 2017, Pages 54–59
ttps://doi.org/10.1016/j.earlhumdev.2017.07.016
Ozlem Bozkurt, [email protected], Nurdan Uras, Fatma Nur Sari, Funda Yavanoglu Atay, Suzan Sahin, Ayse Dogan Alkan, Fuat Emre Canpolat, Serife Suna Oguz
Highlights
There is no consensus regarding the adequate dose of supplementation for preterm infants.
Vitamin D supplementation of 1000 IU/d in very preterm infants effectively decreases the prevalence of vitamin D deficiency.
The clinical importance of biochemically sufficient levels of vitamin D need to be further assessed.
Background
Preterm newborns are born with lower vitamin D stores. Although vitamin D supplementation is recommended there is no consensus regarding the adequate dose of supplementation for preterm infants.
Aims
To assess the effect of three different doses of vitamin D supplementation (400, 800 and 1000 IU/d) in preterm infants ≤ 32 weeks gestation on the prevalence of vitamin D deficiency and 25(OH) D levels at 36 weeks postmenstrual age (PMA).
Study design: Prospective randomized trial.
Subjects: 121 preterm infants with gestational age of 24–32 weeks were randomly allocated to receive 400, 800 or 1000 IU/d vitamin D.
Outcome measures
Serum concentration of 25(OH) D and the prevalence of vitamin D deficiency at 36 weeks PMA. Vitamin D deficiency was defined as serum 25(OH) D concentrations < 20 ng/ml.
Results
Of the 121 infants 72% had deficient vitamin D levels before supplementation. The average 25(OH) vitamin D concentrations at 36 weeks PMA were significantly higher in 800 IU (40 ± 21.4 ng/ml) and 1000 IU group (43 ± 18.9 ng/ml) when compared to 400 IU group (29.4 ± 13 ng/ml). The prevalence of vitamin D deficiency (2.5 vs 22.5; RR: 0.09; CI:0.01–0.74) and insufficiency (30 vs 57.5; RR:0.32; CI:0.13–0.80) was significantly lower in 1000 IU group when compared to 400 IU group at 36 weeks PMA.
Conclusion
1000 IU/d of vitamin D supplementation in preterm infants ≤ 32 weeks gestation age effectively decreases the prevalence of vitamin D deficiency and leads to higher concentrations of 25(OH) vitamin D at 36 weeks PMA
Trial registration Clinical Trials.gov: NCT02941185.
800 IU provided benefits to premies, 400 IU did not - RCT 2017
Randomized trial of two doses of vitamin D3 in preterm infants <32 weeks: Dose impact on achieving desired serum 25(OH)D3 in a NICU population